Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: OHTAC recommendation
Ontario Health Technology Advisory Committee (OHTAC)
Record ID 32017000347
English
Authors' recommendations:
The Ontario Health Technology Advisory Committee accepted the findings of the health
technology assessment conducted by Health Quality Ontario.
There is a large degree of uncertainty in both the clinical and economic evidence for hyperbaric
oxygen therapy, meaning that it is unclear how effective hyperbaric oxygen therapy is and how
cost-effective it is. Given this uncertainty, the Ontario Health Technology Advisory Committee
decided the evidence was insufficient to make a recommendation to publicly fund or not fund
hyperbaric oxygen therapy for treating diabetic foot ulcers.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
http://www.hqontario.ca/Portals/0/documents/evidence/reports/hyperbaric-oxygen-therapy-ohtac-recommendation-may-2017.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Diabetic Foot
- Humans
- Hyperbaric Oxygenation
- Wound Healing
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.